Yahoo Web Search

Search results

1. finance.yahoo.com › news › sorrento-therapeutics-incSorrento Therapeutics, Inc. Announces the Consummation of the ...

   finance.yahoo.com › news › sorrento-therapeutics-inc

   • Cached

   Sep 22, 2023 · Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento" or "Company"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and ...

2. www.prnewswire.com › news-releases › sorrentoSorrento Therapeutics, Inc. Receives Court Approval for $75 ...

   www.prnewswire.com › news-releases › sorrento

   • Cached

   Feb 21, 2023 · However, due to the possibility of certain actions by a litigation creditor, Sorrento and its wholly-owned, non-operating subsidiary Scintilla Pharmaceuticals, Inc. sought chapter 11 relief to ...

3. www.globenewswire.com › news-release › 2023/09/07Sorrento Therapeutics Announces Positive Phase 2a Clinical

   www.globenewswire.com › news-release › 2023/09/07

   • Cached

   Sep 7, 2023 · SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento") announced today positive Phase 2a top-line clinical trial results for the RTX program. The Phase ...

   • Author: Sorrento Therapeutics, Inc.

4. finance.yahoo.com › quote › SRNESorrento Therapeutics, Inc. (SRNE) Stock Price, News, Quote ...

   finance.yahoo.com › quote › SRNE

   • Cached

   Find the latest Sorrento Therapeutics, Inc. (SRNE) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Inovio Pharmaceuticals, Inc. 10.13 ...

5. People also ask

   Who is Sorrento Therapeutics?

   • About Sorrento Therapeutics, Inc. Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19.

   Sorrento Therapeutics, Inc. Announces the Consummation of the

   finance.yahoo.com/news/sorrento-therapeutics-inc-announces-consummation-153800928.html

   See all results for this question

   Is Sorrento a registered trademark?

   • Sorrento® and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc. G-MAB™, DAR-T™, Seprehvec™, SOFUSA™, COVISHIELD™, COVIDROPS™, COVI-MSC™, COVIMARK™,Fujovee™ and Ovydso TM are trademarks of Sorrento Therapeutics, Inc. SEMDEXA™ (SP-102) is a trademark of Semnur Pharmaceuticals, Inc.

   Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million

   www.prnewswire.com/news-releases/sorrento-therapeutics-inc-receives-court-approval-for-75-million-financing-in-chapter-11-case-301752426.html

   See all results for this question

   Who is the legal counsel for Sorrento Therapeutics?

   • Latham & Watkins LLP and Jackson Walker LLP are serving as legal counsel to Sorrento. M3 Partners is serving as restructuring advisor. About Sorrento Therapeutics, Inc. Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19.

   Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million

   www.prnewswire.com/news-releases/sorrento-therapeutics-inc-receives-court-approval-for-75-million-financing-in-chapter-11-case-301752426.html

   See all results for this question

   What does Sorrento do?

   • Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19.

   Sorrento Therapeutics, Inc. Announces the Consummation of the Previo…

   www.prnewswire.com/news-releases/sorrento-therapeutics-inc-announces-the-consummation-of-the-previously-announced-sale-of-substantially-all-of-the-common-shares-preferred-shares-and-warrants-that-sorrento-held-in-scilex-holding-company-301936341.html

   See all results for this question

6. www.globenewswire.com › news-release › 2023/06/13Sorrento Therapeutics, Inc. announces a $4.6 Million U.S.

   www.globenewswire.com › news-release › 2023/06/13

   • Cached

   Jun 13, 2023 · SAN DIEGO, June 13, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, Accessibility: Skip TopNav ... ZTlido ® is a registered trademark owned by Scilex Pharmaceuticals Inc.

   • Author: Sorrento Therapeutics, Inc.

7. www.prnewswire.com › news-releases › sorrentoSorrento Therapeutics, Inc. Announces the Consummation of the ...

   www.prnewswire.com › news-releases › sorrento

   • Cached

   Sep 22, 2023 · /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, ... Medical Pharmaceuticals. Health Care & Hospitals. News Releases in Similar Topics Contact PR Newswire. Call 888-776-0942

8. sorrentotherapeutics.com › who-we-areWho We Are - Sorrento Therapeutics

   sorrentotherapeutics.com › who-we-are

   • Cached

   Overview. Leadership. Contact. Sorrento Therapeutics - We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19.